Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease
Alzheimer's disease (AD) is a chronic, progressive brain degenerative disease that is common in the elderly. So far, there is no effective treatment. The multi-target-directed ligands (MTDLs) strategy has been recognised as the most promising approach due to the complexity of the pathogenesis o...
Saved in:
Main Authors: | Yi Zhou (Author), Ying He (Author), Xue Teng (Author), Jing Mi (Author), Jing Yang (Author), Rongrui Wei (Author), Wenmin Liu (Author), Qinge Ma (Author), Zhenghuai Tan (Author), Zhipei Sang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease
by: Jing Yang, et al.
Published: (2022) -
Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
by: Luca Piemontese, et al.
Published: (2018) -
QT interval prolongation and with donepezil, rivastigmine and galantamine
by: Katie Malone, et al.
Published: (2020) -
Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease
by: Zhipei Sang, et al.
Published: (2022) -
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy
by: Irene Pachón-Angona, et al.
Published: (2019)